Foster Dykema Cabot & Partners, LLC Amgen Inc Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 564 shares of AMGN stock, worth $186,108. This represents 0.02% of its overall portfolio holdings.
Number of Shares
564
Previous 612
7.84%
Holding current value
$186,108
Previous $174 Million
1.27%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding AMGN
# of Institutions
3,055Shares Held
409MCall Options Held
7.19MPut Options Held
6.26M-
Vanguard Group Inc Valley Forge, PA51.9MShares$17.1 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$15.2 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.56 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.77 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.74 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $177B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...